Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Dietary supplement

a technology of dietary supplement and dietary fiber, applied in the field of dietary fiber, can solve the problems of abnormally high or abnormally low concentration, affecting metabolism, disease in a host, etc., and achieve the effects of accelerating vascular disease, reducing vitamin b12 levels, and reducing composition effectiveness

Inactive Publication Date: 2006-04-04
PROETHIC PHARMA
View PDF9 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The present invention provides a dietary supplement and method for treating and preventing prostate disease and vascular disease. The supplement includes a combination of ingredients that promote prostate and vascular health, including herbs, vitamins, and minerals. The ingredients work synergistically to enhance efficacy and improve overall health. The supplement can also reduce serum levels of homocysteine, a risk factor for cardiovascular disease. The invention addresses the need for a more effective and convenient treatment for these diseases."

Problems solved by technology

Aging often leads to abnormally high or abnormally low concentrations of certain enzymes, hormones, vitamins, minerals or other natural elements, thereby affecting metabolism and ultimately causing disease in a host.
This is primarily due to higher levels of the enzyme reductase which causes the conversion of testosterone to DHT which binds to prostatic receptor cells ultimately resulting in prostate enlargement.
As the prostate grows larger it presses against the urethra and bladder, interfering with the normal flow of urine.
Enlargement of the prostate gland can cause many uncomfortable symptoms including a need to urinate often, a weak or interrupted urinary stream, a feeling that you cannot empty your bladder completely, a feeling of delay or hesitation when you start to urinate, a feeling that you must urinate right away and continuing pain in the lower back, pelvis or upper thighs.
In some cases the transformation of testosterone to DHT is believed to cause prostate cancer.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0072]Caplets, each containing the following active ingredients for treatment or prevention of BHP, prostate cancer and / or vascular disease:[0073]320 mg saw palmetto extract, yielding 144 mg of fatty acids and sterols[0074]62 mg of d-alpha tocopheryl succinate[0075]12.5 mg of d-gamma tocopherol[0076]4.5 mg of mixed tocopherols including d-delta tocopherol and d-beta tocopherol[0077]100 mcg of selenium chelate[0078]2.5 mg of lycopene complex[0079]7.5 mg of zinc gluconate[0080]1 mg of folic acid[0081]250 mcg of cyanocobalamin[0082]12.5 mg of pyridoxine HCL

Other ingredients include dicalcium phosphate as a tableting excipient and carrier for folic acid and cyanocobalamin; cellulose as a tableting excipient; maltodextrin as a carrier for saw palmetto extract and natural vitamin E oils; microcrystalline cellulose as a tableting excipient; modified corn starch as a tableting excipient; soy protein, enzymes, sodium selenite and citric acid contained within the selenium chelate; silica as a...

example 2

[0083]Caplets, each containing the following active ingredients for treatment or prevention of prostate cancer and / or vascular disease:[0084]124 mg of d-alpha tocopheryl succinate[0085]25 mg of d-gamma tocopherol[0086]9 mg of mixed tocopherols including d-delta tocopherol and d-beta tocopherol[0087]200 mcg of selenium chelate[0088]5 mg of lycopene complex[0089]15 mg of zinc gluconate[0090]2 mg of folic acid[0091]500 mcg of cyanocobalamin[0092]25 mg of pyridoxine HCL.

Other ingredients include dicalcium phosphate as a tableting excipient and carrier for folic acid and cyanocobalamin; cellulose as a tableting excipient; maltodextrin as a carrier for natural vitamin E oils; microcrystalline cellulose as a tableting excipient; modified corn starch as a tableting excipient; soy protein, enzymes, sodium selenite and citric acid contained within the selenium chelate; silica as a tableting excipient; sucrose and corn starch contained in the lycopene complex; polyvinylpyrrolidone as a tableti...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
weightaaaaaaaaaa
concentrationsaaaaaaaaaa
molecular weightaaaaaaaaaa
Login to View More

Abstract

A dietary supplement for treating or preventing prostate disease and / or vascular disease including saw palmetto, d-alpha tocopherol, d-gamma tocopherol, d-delta tocopherol, d-beta tocopherol, selenium, lycopene, zinc, folic acid, vitamin B12, and vitamin B6, each in a therapeutically effective amount.

Description

[0001]The present application is a continuation in part of U.S. Ser. No. 10 / 787,350, filed Feb. 26, 2004 now abandoned.FIELD OF INVENTION[0002]The present invention relates generally to a dietary supplement including vitamins, micronutrients and phytotherapeutic compounds, the supplement being adapted for administration to a host for treating or preventing conditions related to aging. More particularly, this invention relates to a dietary supplement adapted for administration to a male host for treating or preventing prostate disease and / or vascular disease, the active components of the supplement including saw palmetto, vitamin E, selenium, lycopene, zinc, vitamin B12, vitamin B6 and folic acid.BACKGROUND OF THE INVENTION[0003]Aging often leads to abnormally high or abnormally low concentrations of certain enzymes, hormones, vitamins, minerals or other natural elements, thereby affecting metabolism and ultimately causing disease in a host. Frequently, these diseases can be treated ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(United States)
IPC IPC(8): A61K36/889A23L33/15A61K31/01A61K31/355A61K31/4415A61K31/519A61K31/525A61K31/714A61K33/04A61K33/32A61K45/06
CPCA23L1/302A61K45/06A61K33/32A61K33/04A61K31/714A61K31/519A61K31/4415A61K31/355A61K31/01A23V2002/00A23V2250/2114A23V2250/712A23V2250/1626A23V2250/213A23V2250/1642A23V2250/7056A23V2250/7052A23V2250/706A23L33/15
Inventor HARVEY, BRYCE M.KNIGHT, PHILIP M.
Owner PROETHIC PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products